Skip to content

Equity Exposures

Equity exposures receive dedicated risk weight treatment separate from credit risk. Under CRR, the calculator supports SA (Article 133) and IRB Simple (Article 155). Under Basel 3.1, only SA applies.

Overview

Equity exposures are routed directly from classification to the equity calculator, bypassing CRM processing (collateral is not applied to equity holdings).

flowchart LR
    A[Classified Exposures] --> B{Exposure Class}
    B -->|Equity| C[Equity Calculator]
    B -->|Other| D[CRM Processor]
    C --> E[Aggregator]
    D --> E

CRR Article 133 - Standardised Approach (SA)

Under CRR, Art. 133(2) assigns a flat 100% risk weight to all equity exposures (except central bank sovereign equity at 0%). There is no differentiation by equity type — listed, unlisted, PE, and speculative all receive 100%.

Equity Type Risk Weight Reference
Central bank / sovereign equity 0% Sovereign treatment
All other equity (listed, unlisted, PE, etc.) 100% Art. 133(2) flat

Under Basel 3.1, equity that is unlisted and where the business has existed for less than five years is classified as "higher-risk" (400%, Art. 133(4)). PE/VC is only higher-risk if it meets both criteria — long-established PE holdings receive standard 250%.

Common Confusion: CRR vs Basel 3.1 Art. 133

CRR Art. 133 assigns a flat 100% to all equity. Basel 3.1 rewrites Art. 133 with differentiated weights: 250% (standard), 400% (higher risk), 150% (subordinated debt), 100% (legislative). Do not confuse the two. See the Equity Approach Specification for full details including CIU treatment and the Basel 3.1 transitional schedule.

Calculation:

RWA = EAD x Risk Weight

Article 155 - IRB Simple Risk Weight Method

For firms with IRB permission, a different risk weight schedule applies:

Equity Type Risk Weight Reference
Exchange-traded / Listed 290% Art. 155(2)(a)
Private equity (diversified portfolios) 190% Art. 155(2)(b)
All other equity (unlisted, speculative, CIU, other) 370% Art. 155(2)(c)

Art. 155 has exactly three categories

CRR Art. 155(2) defines only the three risk weight buckets shown above. The code additionally maps GOVERNMENT_SUPPORTED and CENTRAL_BANK equity types to 190% and 0% respectively — these are implementation-specific mappings with no direct basis in Art. 155 text. Government-supported equity at 100% under SA (Art. 133) is a legislative programme treatment, not an IRB Simple category. See D3.4 in DOCS_IMPLEMENTATION_PLAN.md and the Equity Approach Specification for details.

Diversified Portfolio Treatment

Private equity holdings in a diversified portfolio receive a reduced risk weight of 190% (vs 370% for non-diversified). This is flagged via the is_diversified_portfolio attribute.

Short-Position Netting (Art. 155(2))

Art. 155(2) permits limited netting of short equity positions against long positions under the Simple Risk Weight Approach. The conditions are strict:

  • Same individual stock — short cash positions and derivatives held in the non-trading book may offset long positions in the same individual stock.
  • Explicit hedge — the hedging relationship must be explicit (designated and documented), not an incidental offset.
  • Minimum residual maturity of 1 year — the hedge must cover the long position for at least one year.

Short positions that do not meet these criteria are treated as if they were long positions, with the relevant Art. 155(2) risk weight applied to the absolute value of the short position. Netting cannot reduce the gross long exposure for risk-weighting purposes outside the explicit-hedge case.

Netting is per-stock, not portfolio-level

Art. 155(2) netting is between long and short positions in the same individual stock. It is not a basket-level or sector-level offset. See the CRR Equity Approach Specification for the verbatim Art. 155(2) text.

PD/LGD Approach Per-Exposure Cap (Art. 155(3))

Firms with permission to use the Art. 155(3) PD/LGD approach for equity compute RWEA via the Art. 153(1) corporate IRB formula, using the equity-specific PD floors (Art. 165(1): 0.09% / 0.40% / 1.25%) and LGDs (Art. 165(2): 90%, or 65% for sufficiently diversified PE), with M = 5 years (Art. 165(3)).

CRR Art. 155(3) imposes an individual-exposure capital cap on the PD/LGD output:

EL × 12.5 + RWEA  ≤  EAD × 12.5

Equivalently, the total risk-based capital implied by a single equity exposure (expected-loss cover plus 8% × RWEA) cannot exceed a 100% loss assumption on the exposure value. This bites when the underlying PD and LGD combination would otherwise drive the per-exposure capital above one-for-one EAD coverage — typically only for near-default equity holdings.

The cap operates per individual exposure, not at portfolio level. It is the counterpart to (but distinct from) the portfolio-level IMA floor in Art. 155(4) below.

Worked Example — Non-Binding Case

Listed PE holding under PD/LGD, EAD = £100, PD = 0.40%, LGD = 90% (Art. 165(2) non-diversified), giving an Art. 153(1) RW ≈ 370% (illustrative — exact value depends on the corporate K-formula with the 0.40% PD floor):

RWEA      = £100 × 370%       = £370
EL        = £100 × 0.40% × 90% = £0.36
EL × 12.5 = £0.36 × 12.5      = £4.50
LHS       = £370 + £4.50      = £374.50
RHS       = £100 × 12.5       = £1,250
Cap       = LHS ≤ RHS         → not binding (£374.50 ≪ £1,250)

Worked Example — Binding Case

Same exposure but with PD = 80% (a near-default unrated holding) and the Art. 178 default-definition information condition unmet, so the 1.5× scaling factor in Art. 155(3) applies. With LGD = 90% and an illustrative scaled RW = 1,500% from the PD/LGD formula:

RWEA       = £100 × 1,500%     = £1,500
EL         = £100 × 80% × 90%  = £72
EL × 12.5  = £72 × 12.5        = £900
LHS        = £1,500 + £900     = £2,400
RHS        = £100 × 12.5       = £1,250
Cap        = LHS ≤ RHS         → BINDING (£2,400 > £1,250)

Capped RWEA = (RHS − EL × 12.5) = £1,250 − £900 = £350

Result: PD/LGD RWEA is reduced from £1,500 to £350 to satisfy the Art. 155(3) cap.

Cap applies only to PD/LGD (Art. 155(3)), not to Simple (Art. 155(2))

The per-exposure cap is part of the PD/LGD approach mechanics. It does not apply to the Simple Risk Weight Approach in Art. 155(2), where 190% / 290% / 370% are calibrated risk weights without a separate EL component. See the canonical text and full PD/LGD parameter table in the CRR Equity Approach Specification — PD/LGD Approach.

Removed under Basel 3.1

PRA PS1/26 Art. 147A abolishes the Art. 155(3) PD/LGD approach (alongside Simple and IMA). From 1 January 2027, all equity exposures must use SA (Art. 133), so the Art. 155(3) per-exposure cap has no successor in the Basel 3.1 framework. The Rules 4.4–4.10 transitional applies to the Simple Risk Weight Approach output, not to PD/LGD RWEA.

Implementation status

The current calculator implements only the Simple Risk Weight Approach (Art. 155(2)) under IRB equity — the PD/LGD approach (Art. 155(3)) is not yet implemented (tracked as P1.153 in IMPLEMENTATION_PLAN.md). The Art. 155(3) per-exposure cap therefore does not bite in any current calculation path. Once the PD/LGD approach is built, the cap becomes a mandatory post-RWEA adjustment on PD/LGD-routed equity exposures.

Internal Models Approach (Art. 155(4))

Firms with PRA permission for the IRB Internal Models Approach (IMA) for equity calculate RWEA as 12.5 × potential loss, where potential loss is derived from an internal VaR model at the 99th percentile, one-tailed confidence interval on the difference between quarterly returns and an appropriate risk-free rate, computed over a long-term sample period.

Art. 155(4) IMA floor — the IMA portfolio-level RWEA must not be lower than the floor computed as the sum of:

Floor RWEA (Art. 155(4)) = PD/LGD RWEA (Art. 155(3)) + EL × 12.5

where both PD/LGD RWEA and EL are computed using the Art. 165(1) PD floors and Art. 165(2) LGD values for equity. This is a portfolio-level floor that bites when the firm's internal VaR estimate is more optimistic than the regulatory PD/LGD output.

Art. 155(4) floor vs Art. 155(3) per-exposure cap

The Art. 155(4) IMA floor (PD/LGD RWEA + EL × 12.5) is a lower bound on the IMA portfolio output. It is distinct from the Art. 155(3) per-exposure cap (EL × 12.5 + RWEA ≤ EAD × 12.5), which limits the PD/LGD output of any single exposure to a 100% loss assumption. The two operate on different approaches (IMA vs PD/LGD) and at different levels (portfolio vs exposure).

See the CRR Equity Approach Specification for the full IMA mechanics including Art. 165 PD floors and LGD values used in the floor computation.

CRR Only — Removed Under Basel 3.1

The IRB Simple Risk Weight Method (Article 155(2)), the PD/LGD Approach (Art. 155(3)), and the Internal Models Approach (Art. 155(4)) all apply only under CRR. Under Basel 3.1 (PRA PS1/26 Art. 147A), the entire IRB Equity Approach is abolished — all equity exposures must use Art. 133 SA treatment (250% / 400%). The change is phased in via PRA Rules 4.4–4.10 (transitional 2027–2029) for firms that held IRB permission on 31 December 2026, after which only SA applies. See the Basel 3.1 Equity Approach Specification and the CRR Equity Transitional Schedule.

Approach Determination

The equity approach depends on the regulatory framework and IRB permissions:

Framework IRB Permission Equity Approach
CRR SA only Article 133 (SA)
CRR IRB permitted Article 155 (IRB Simple)
Basel 3.1 Any Article 133 (SA) — IRB equity removed

Example

Equity holding: Listed shares, £2m

SA Treatment (Article 133):

RWA = £2,000,000 x 100% = £2,000,000

IRB Simple Treatment (Article 155):

RWA = £2,000,000 x 290% = £5,800,000

Regulatory References

Topic Reference
SA equity treatment CRR Art. 133
IRB simple risk weight CRR Art. 155
Strategic equity treatment EBA Q&A 2023_6716